DK2968377T3 - Sammensætninger og fremgangsmåder til behandling af en infektionssygdom - Google Patents

Sammensætninger og fremgangsmåder til behandling af en infektionssygdom Download PDF

Info

Publication number
DK2968377T3
DK2968377T3 DK14779275.8T DK14779275T DK2968377T3 DK 2968377 T3 DK2968377 T3 DK 2968377T3 DK 14779275 T DK14779275 T DK 14779275T DK 2968377 T3 DK2968377 T3 DK 2968377T3
Authority
DK
Denmark
Prior art keywords
compositions
treating
methods
infectious disease
infectious
Prior art date
Application number
DK14779275.8T
Other languages
English (en)
Inventor
Laszlo Sichtnik
Original Assignee
Laszlo Sichtnik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laszlo Sichtnik filed Critical Laszlo Sichtnik
Application granted granted Critical
Publication of DK2968377T3 publication Critical patent/DK2968377T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK14779275.8T 2013-03-12 2014-03-12 Sammensætninger og fremgangsmåder til behandling af en infektionssygdom DK2968377T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361777484P 2013-03-12 2013-03-12
PCT/US2014/024262 WO2014165057A1 (en) 2013-03-12 2014-03-12 Compositions and methods for treating infectious disease

Publications (1)

Publication Number Publication Date
DK2968377T3 true DK2968377T3 (da) 2020-08-24

Family

ID=51659056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14779275.8T DK2968377T3 (da) 2013-03-12 2014-03-12 Sammensætninger og fremgangsmåder til behandling af en infektionssygdom

Country Status (6)

Country Link
US (2) US10183964B2 (da)
EP (1) EP2968377B1 (da)
DK (1) DK2968377T3 (da)
ES (1) ES2827197T3 (da)
HU (1) HUE050413T2 (da)
WO (1) WO2014165057A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017143362A1 (en) * 2016-02-18 2017-08-24 Drabinsky Michael Earl Treatment for protozoa borne illness
WO2017143361A1 (en) * 2016-02-18 2017-08-24 Drabinsky Michael Earl Treatment for spirochete borne illness
RU2704980C1 (ru) * 2019-03-28 2019-11-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Донской государственный аграрный университет" Способ лечения при пиометре и эндометрите у собак
US11179575B2 (en) 2019-10-15 2021-11-23 Cedars-Sinai Medical Center Internal ultraviolet therapy
US20210252045A1 (en) * 2019-12-11 2021-08-19 John I. Toohey Method for inactivating and removing disease-related levels of sulfane sulfur from affected biological tissues with special relevance to Covid-19 virus infection
US20240350492A1 (en) 2020-07-10 2024-10-24 Ting Therapeutics Llc Methods for the Prevention and Treatment of Hearing Loss
IL308209A (en) * 2021-05-05 2024-01-01 Cedars Sinai Medical Center Exposure to UVA light increases mitochondrial antiviral protein expression in tracheal cells through cell-to-cell communication and its uses
RU2765542C1 (ru) * 2021-07-08 2022-01-31 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Способ прогнозирования степени тяжести острого бактериального холангиогепатита у кошек

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB788855A (en) * 1953-06-30 1958-01-08 Ernst Theodore Krebs Improvements in or relating to mandelo-nitrile-glucuronosides and method of making the same
FR2461498A1 (fr) * 1979-07-24 1981-02-06 Somet Procede de preparation de solutions concentrees d'amygdaline sous sa forme naturelle, et produits ainsi obtenus
JP3856680B2 (ja) * 2001-10-09 2006-12-13 ポーラ化成工業株式会社 発ガンプロモーター抑制剤及びそれを含有する組成物
WO2006009418A1 (es) * 2004-07-21 2006-01-26 Luis De La Llata Romero Obtención de los glicósidos cianogénico y relacionados, más derivados genínicos y sapogenínicos de plantas de la familia sapotácea para la preparación de cosméticos y composiciones dermatológicas
EP1778359B1 (en) * 2004-08-08 2010-10-13 KHAYAT, Eli Pharmaceutical compositions for alleviating excess levels of sugar in diabetic patients
DE102007052223A1 (de) * 2007-10-31 2009-05-14 Bionorica Ag Hydrolysate aus Pflanzenextrakten sowie diese enthaltendes antibakterielles Mittel
WO2011005841A1 (en) * 2009-07-08 2011-01-13 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions
CN102702282B (zh) * 2012-06-04 2014-11-26 西安天丰生物科技有限公司 一种从杏仁油渣中分离苦杏仁甙的方法

Also Published As

Publication number Publication date
EP2968377A1 (en) 2016-01-20
ES2827197T3 (es) 2021-05-20
US10723751B2 (en) 2020-07-28
US10183964B2 (en) 2019-01-22
WO2014165057A1 (en) 2014-10-09
HUE050413T2 (hu) 2020-12-28
EP2968377A4 (en) 2016-11-23
US20190144483A1 (en) 2019-05-16
US20160002277A1 (en) 2016-01-07
EP2968377B1 (en) 2020-07-22

Similar Documents

Publication Publication Date Title
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK3080274T3 (da) Fremgangsmåder og sammensætninger til genom-manipulation
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK2970456T3 (da) Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
DK2984166T3 (da) Sammensætninger til behandling af mpsi
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK3019503T3 (da) Polycykliske-carbamoylpyridon-forbindelser og anvendelse deraf til behandling af hiv-infektioner
DK3019499T3 (da) Polycykliske-carbamoylpyridon-forbindelser og anvendelse deraf til behandling af hiv-infektioner
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3300610T3 (da) Fremgangsmåde til fraktionering af opløselige ærter
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
EP2967969C0 (en) IMPLANT
IL241461B (en) Methods for treating osteogenesis imperfecta
DK2968099T3 (da) Metoder og sammensætninger til rengøring og desinfektion af overflader
DK3065771T3 (da) Fremgangsmåder og sammensætninger til vedvarende immunterapi
DK2903967T3 (da) Acylaminopyrimidinderivater til behandling af virusinfektioner og yderligere sygdomme
DK2967049T3 (da) Metoder, forbindelser og sammensætninger til behandlingen af angiotensin relaterede sygdomme
DK3076786T3 (da) Fælde
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
EP2958994A4 (en) Vaccine composition
DK2961378T3 (da) Fremgangsmåder til behandlingen af mitochondrisk sygdom
DK2979399T3 (da) Fremgangsmåde og anordning til justering af latenstid